Skip to main content
. Author manuscript; available in PMC: 2016 Nov 7.
Published in final edited form as: Gastrointest Endosc. 2011 Sep;74(3):496–503.e3. doi: 10.1016/j.gie.2011.05.022

TABLE 3.

Primary model results

Vomiting Nausea Total symptom score
Session 1 Slope (daily change) Group A (Stim on) −0.40 (95% CI, −0.51 to −0.29); P < .001 −0.33 (95% CI, −0.45 to −0.22); P < .001 −1.30 (95% CI, 01.76 to −0.85); P < .001
Group B (Stim off) −0.28 (95% CI, −0.40 to −0.17); P < .001 −0.40 (95% CI, −0.51 to −0.28); P < .001 −1.63 (95% CI, −2.10 to −1.16); P < .001
Session 2 Slope (daily change) Group A (Stim off) 0.08 (95% CI, −0.08 to 0.23) P < .329 −0.02 (95% CI, −0.18 to 0.14); P < .841 −0.20 (95% CI, −0.83 to 0.42); P < .516
Group B (Stim on) −0.04 (95% CI, −0.19 to 0.11); P = .606 0.04 (95% CI, −0.12 to 0.21); P < .585 0.12 (95% CI, −0.51 to 0.75); P < .700
Treatment effect pooled across periods −0.12 (95% CI, −0.26 to 0.03); P = .116 −0.06 (95% CI, −0.21 to 0.09); P = .431 −0.33 (95% CI, −0.92 to 0.27); P = .277

Model: treatment effect pooled over period, adjusted for age and sex.

Negative values indicate decreases in symptoms.

See Online Appendix Table for additional models with treatment effect by period examinations.

Stim, Stimulation.